Endothelin-1 Downregulates Angiotensin-Converting Enzyme-2 Expression in Human Bronchial Epithelial Cells
Authors:
- Yamin LiYLYamin Li
- Yan ZengYZYan Zeng
- Renrong WuRWRenrong Wu
- Jianjun OuJOJianjun Ou
- 5 June 2013
- journal article
- Published by S. Karger AG in Pharmacology
- Vol. 91 (5-6) , 297-304
Abstract
Background/Aims: Both endothelin-1 (ET-1) and the renin-angiotensin system (RAS) are implicated in the pathogenesis and progression of chronic obstructive pulmonary disease (COPD). In the present study, we explored the interaction between ET-1 and the RAS by examining the effect of ET-1 on angiotensin-converting enzyme-2 (ACE2) expression and activity in human bronchial epithelial cells (HBEpCs). Methods: HBEpCs were treated with ET-1 (1, 10, 20, 40 or 50 nmol/l) for 6, 12, 18, 24 or 30 h with or without the transcription inhibitor actinomycin D, endothelin A (ETA) receptor blocker BQ123, endothelin B receptor blocker BQ788, or different kinase inhibitors. Results: ET-1 decreased the ACE2 mRNA level in a dose- and time-dependent manner within 24 h, which led to dose-dependent downregulation of the ACE2 promoter activity, protein level and the cell membrane ACE2 activity. Actinomycin D (1 mg/ml), BQ123 (1 μmol/l), and the p38 mitogen-activated protein kinase (MAPK) siRNA and inhibitor PD169316 (25 μmol/l) completely abolished the effect of ET-1 on ACE2 expression in HBEpCs. Conclusion: ET-1 downregulates ACE2 expression and activity at the transcription level in HBEpCs via the ETA receptor by a p38 MAPK-dependent mechanism. This is the first evidence of crosstalk between the ET-1/ETA axis and the RAS in regard to the pathogenesis and progression of COPD.Keywords
This publication has 22 references indexed in Scilit:
- Local Renin-Angiotensin II Systems, Angiotensin-Converting Enzyme and its Homologue ACE2: Their Potential Role in the Pathogenesis of Chronic Obstructive Pulmonary Diseases, Pulmonary Hypertension and Acute Respiratory Distress SyndromeCurrent Medicinal Chemistry, 2011
- Angiotensin II revisited: new roles in inflammation, immunology and agingEMBO Molecular Medicine, 2010
- Progression of chronic obstructive pulmonary disease: impact of inflammation, comorbidities and therapeutic interventionCurrent Medical Research and Opinion, 2009
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2007
- ACE2: A New Target for Cardiovascular Disease TherapeuticsJournal of Cardiovascular Pharmacology, 2007
- Oxidative stress and redox regulation of lung inflammation in COPDEuropean Respiratory Journal, 2006
- ACE2: A novel therapeutic target for cardiovascular diseasesProgress in Biophysics and Molecular Biology, 2006
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005
- The Pulmonary Renin-Angiotensin SystemCurrent Pharmaceutical Design, 2003
- Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related CarboxypeptidaseJournal of Biological Chemistry, 2002